Method for long-term ex vivo maintenance or expansion of human erythroblast, human megakaryocyte-erythroid progenitor, or human common myeloid progenitor cell and application thereof
AssigneeOcgene Therapeutics Corporation
InventorsChang TONG, Yibin LIN, Kangtao LV
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for long-term ex vivo maintenance or expansion of one or more of a human erythroblast, a human megakaryocyte-erythroid progenitor, or a human common myeloid progenitor, comprising the step of: culturing cells comprising one or more of those cells in a culture medium comprising one or more selected from a tankyrase inhibitor, a growth factor, a B-Raf kinase inhibitor and a GSK-3 inhibitor.
Claims22
A method for long-term ex vivo maintenance or expansion of one or more of a human erythroblast, a human megakaryocyte-erythroid progenitor, or a human common myeloid progenitor, comprising the step of:
- culturing the cells comprising one or more of the human erythroblast, the human megakaryocyte-erythroid progenitor, or the human common myeloid progenitor in a culture medium, wherein the culture medium comprises one or more selected from a tankyrase inhibitor, a growth factor, a B-Raf kinase inhibitor and a GSK-3 inhibitor.
Dependencies are inferred from the claim text.